Match!
Kiran K. Turaga
University of Chicago
170Publications
25H-index
2,157Citations
Publications 173
Newest
#1M. Haroon A. Choudry (University of Pittsburgh)H-Index: 3
#2David L. Bartlett (University of Pittsburgh)H-Index: 49
Last.Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 4 authors...
Source
Source
Background Advances in the molecular biology of tumor metastasis have paralleled the evolution in the management of metastatic disease from colorectal cancer. In this review, we summarize the current understanding of the mechanism of colorectal cancer metastases, in particular that of peritoneal metastases, as well as clinical data on the treatment of this disease.
Source
#1Elizabeth Poli (U of C: University of Chicago)H-Index: 3
#2Andrew M. Millis (U of C: University of Chicago)
Last.Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 9 authors...
Source
#1Abhineet Uppal (U of C: University of Chicago)H-Index: 9
#2Fabrice Smieliauskas (WSU: Wayne State University)
Last.Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 7 authors...
Source
Periampullary cancers, including adenocarcinoma from the duodenum, pancreas, bile duct and ampulla, represent a spectrum of malignancies with varying biological behavior and outcomes. In particular ampullary adenocarcinoma (AAC) is a rare, poorly understood disease with an incidence of <1/100,000 cases, compromises only 0.2% of gastrointestinal cancers and is frequently grouped together with other periampullary cancers (1).
#1Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
#2T. Clark Gamblin (MCW: Medical College of Wisconsin)H-Index: 36
Last.David Bartlett (University of Pittsburgh)H-Index: 18
view all 5 authors...
Source
#1Alejandro Plana (U of C: University of Chicago)H-Index: 1
#2Thomas G. Cotter (U of C: University of Chicago)H-Index: 6
Last.Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 3 authors...
A 55-year-old woman presented with a 2-day history of abdominal pain, multiple episodes of non-bloody, non-bilious emesis and inability to tolerate oral intake. Her medical history included recurrent small bowel obstructions status-post multiple exploratory laparotomies and decompressive gastrostomy
Source
#1Francisco Izquierdo (U of C: University of Chicago)
#2Scott K. Sherman (U of C: University of Chicago)H-Index: 9
Last.Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 4 authors...
Source
#1Daniel V.T. Catenacci (U of C: University of Chicago)H-Index: 25
#2Leah Chase (U of C: University of Chicago)H-Index: 1
Last.Mitchell C. Posner (U of C: University of Chicago)H-Index: 47
view all 20 authors...
4050Background: Complete resection (R0) and pathologic response grade (PRG) correlate with long-term GEA outcome. FOLFIRINOX demonstrated efficacy in advanced GEA; gFOLFIRINOX improved tolerability...
Source
12345678910